JPMorgan Chase & Co’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.7M | Buy |
258,965
+231,579
| +846% | +$19.4M | ﹤0.01% | 1689 |
|
|
2025
Q1 | $1.96M | Buy |
27,386
+3,662
| +15% | +$262K | ﹤0.01% | 3263 |
|
|
2024
Q4 | $1.07M | Buy |
23,724
+9,809
| +70% | +$441K | ﹤0.01% | 3755 |
|
|
2024
Q3 | $703K | Buy |
13,915
+3,666
| +36% | +$185K | ﹤0.01% | 3841 |
|
|
2024
Q2 | $418K | Buy |
10,249
+9,301
| +981% | +$379K | ﹤0.01% | 3937 |
|
|
2024
Q1 | $40.6K | Buy |
948
+267
| +39% | +$11.4K | ﹤0.01% | 5041 |
|
|
2023
Q4 | $27.4K | Sell |
681
-32,495
| -98% | -$1.31M | ﹤0.01% | 5175 |
|
|
2023
Q3 | $979K | Buy |
33,176
+33,170
| +552,833% | +$979K | ﹤0.01% | 3415 |
|
|
2023
Q2 | $26 | Sell |
6
-69,869
| -100% | -$303K | ﹤0.01% | 5868 |
|
|
2023
Q1 | $150K | Buy |
69,875
+69,869
| +1,164,483% | +$150K | ﹤0.01% | 4475 |
|
|
2022
Q4 | $0 | Sell |
6
-4
| -40% | – | ﹤0.01% | 5894 |
|
|
2022
Q3 | $0 | Buy |
10
+4
| +67% | – | ﹤0.01% | 5789 |
|
|
2022
Q2 | $0 | Sell |
6
-101
| -94% | – | ﹤0.01% | 5882 |
|
|
2022
Q1 | $0 | Buy |
107
+101
| +1,683% | – | ﹤0.01% | 5923 |
|
|
2021
Q4 | $0 | Hold |
6
| – | – | ﹤0.01% | 5890 |
|
|
2021
Q3 | $0 | Sell |
6
-195
| -97% | – | ﹤0.01% | 5720 |
|
|
2021
Q2 | $3K | Sell |
201
-10,870
| -98% | -$162K | ﹤0.01% | 5348 |
|
|
2021
Q1 | $209K | Buy |
11,071
+551
| +5% | +$10.4K | ﹤0.01% | 4433 |
|
|
2020
Q4 | $305K | Buy |
10,520
+7,742
| +279% | +$224K | ﹤0.01% | 4008 |
|
|
2020
Q3 | $86K | Buy |
2,778
+937
| +51% | +$29K | ﹤0.01% | 4113 |
|
|
2020
Q2 | $61K | Buy |
+1,841
| New | +$61K | ﹤0.01% | 4149 |
|
|
2018
Q1 | – | Sell |
-60
| Closed | -$2K | – | 4780 |
|
|
2017
Q4 | $2K | Buy |
+60
| New | +$2K | ﹤0.01% | 4606 |
|